机构

• 上海药物研究所 [47]

采集方式

• OAI收割 [47]

内容类型

• 期刊论文 [47]

发表日期

• 2024 [1]
• 2023 [5]
• 2022 [2]
• 2021 [1]
• 2020 [1]
• 2019 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共47条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 7-Dehydrocholesterol dictates ferroptosis sensitivity 期刊论文  OAI收割 NATURE, 2024, 卷号: 626, 期号: 7998, 页码: 29 作者:  Li, Yaxu;  Ran, Qiao;  Duan, Qiuhui;  Jin, Jiali;  Wang, Yanjin   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/09 A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects 期刊论文  OAI收割 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 卷号: 191, 页码: 9 作者:  Yang, Xin-Mei;  Yang, Yang;  Yao, Bu-Fan;  Ye, Pan-Pan;  Xu, Yan   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/12/11 COVID-19  Simnotrelvir  Safety  Pharmacokinetics  Healthy subjects   Circuit-specific gene therapy reverses core symptoms in a primate Parkinson's disease model 期刊论文  OAI收割 CELL, 2023, 卷号: 186, 期号: 24, 页码: 5394-+ 作者:  Chen, Yefei;  Hong, Zexuan;  Wang, Jingyi;  Liu, Kunlin;  Liu, Jing   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/01/26 STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy 期刊论文  OAI收割 NATIONAL SCIENCE REVIEW, 2023, 卷号: 10, 期号: 10, 页码: 16 作者:  Zhou, Lei;  Yi, Wenzhe;  Zhang, Zehong;  Shan, Xiaoting;  Zhao, Zitong   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 vaccine  mRNA  STING  cancer immunotherapy  nanoparticles   Identification of lignans as ATP citrate lyase (ACLY) inhibitors from the roots of Pouzolzia zeylanica 期刊论文  OAI收割 NATURAL PRODUCT RESEARCH, 2023, 页码: 8 作者:  Li, Jin-Long;  Jiang, Jia-Yi;  Gu, Shan-Shan;  Zhang, Lei;  Sun, Yan   |  收藏  |  浏览/下载：10/0  |  提交时间：2023/10/17 Pouzolzia zeylanica  lignans  ATP citrate lyase (ACLY) inhibitors   Design, Synthesis, and Biological Evaluation of Bipyridazine Derivatives as Stimulator of Interferon Genes (STING) Receptor Agonists 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 5, 页码: 3327-3347 作者:  Shan, Bin;  Hou, Hui;  Zhang, Keke;  Li, Rui;  Shen, Chang   |  收藏  |  浏览/下载：2/0  |  提交时间：2024/03/27 Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia 期刊论文  OAI收割 CELL RESEARCH, 2022, 页码: 19 作者:  Hu, Cheng-Long;  Chen, Bing-Yi;  Li, Zijuan;  Yang, Tianbiao;  Xu, Chun-Hui   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/12/13 Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 9 作者:  Qian, Hong-jie;  Wang, Yu;  Zhang, Meng-qi;  Xie, Yuan-chao;  Wu, Qing-qing   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/06/15 VV116  nucleoside analog  SARS-CoV-2  safety  pharmacokinetics  healthy subjects   Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel alpha-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2021, 卷号: 115, 页码: 17 作者:  Xie, Hong-Xu;  Zhang, Juan;  Li, Yue;  Zhang, Jin-He;  Liu, Shan-Kui   |  收藏  |  浏览/下载：67/0  |  提交时间：2021/11/04 Tetrahydrobenzo[b]thiophen-2-yl)urea  alpha-Glucosidase inhibitors  Non-competitive inhibitor  Molecular docking  Anti-hyperglycaemic activity  Type 2 diabetes   Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Su, Hai-xia;  Yao, Sheng;  Zhao, Wen-feng;  Li, Min-jun;  Liu, Jia   |  收藏  |  浏览/下载：62/0  |  提交时间：2020/12/24 SARS-CoV-2  3CL protease  traditional Chinese medicines  Shuanghuanglian oral liquid  baicalin  baicalein